Buy $TLRY - NRPicks 14 Mar
Tilray, Inc. is dedicated to the research, cultivation, processing and distribution of medical cannabis. The company offers its products to patients, doctors, clinics, pharmacies, governments and hospitals.
The Ministry of Health and the New Zealand Medicinal Cannabis Agency grant Tilray the first approval under the new Medicinal Cannabis Plan to launch medicinal cannabis products across the country, which will undoubtedly have a major impact on revenue of the company.
During the week, most sectors showed a recovery, however, the marijuana companies had a controlled upside and this is likely to continue. We consider that Tilray is in the middle of its journey.
Technical:
- Average RSI levels
- Buying force 143M buying volume last week.
- Bounce on MA100
The Ministry of Health and the New Zealand Medicinal Cannabis Agency grant Tilray the first approval under the new Medicinal Cannabis Plan to launch medicinal cannabis products across the country, which will undoubtedly have a major impact on revenue of the company.
During the week, most sectors showed a recovery, however, the marijuana companies had a controlled upside and this is likely to continue. We consider that Tilray is in the middle of its journey.
Technical:
- Average RSI levels
- Buying force 143M buying volume last week.
- Bounce on MA100
Dagangan ditutup: hentian tercapai
23 Mar
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.